You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 52 No. 5, NOVEMBER 1933 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

EFFECT OF ALKALI ON THE ABSORPTION OF THYROXINE FROM THE GASTROINTESTINAL TRACT

WITH A NOTE ON THE COMPARATIVE EFFECTS OF SYNTHETIC AND "NATURAL" THYROXINE INJECTED INTRAVENOUSLY

WILLARD O. THOMPSON, M.D.; PHEBE K. THOMPSON, M.D.; LOIS F. N. DICKIE, B.S.; JOSEPH M. ALPER, M.D.

Arch Intern Med. 1933;52(5):809-820.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We have just reported observations which show that when thyroxine is administered by mouth in the form of its monosodium salt to patients with myxedema it has only about from one-third to one-fifth as much effect as when it is administered intravenously in alkaline solution (sodium hydroxide).1 This conclusion was based on the amounts of the two substances which had to be administered every day in order to hold the basal metabolism at the normal level. Pure thyroxine had much less effect than its monosodium salt. Since when thyroxine is dissolved in an excess of sodium hydroxide the disodium salt is presumably formed, it seemed logical to try the effect of administering the hormone by mouth in an alkaline solution.

Klein2 reported that Hoffmann-La Roche thyroxine solution for oral use, Schering thyroxine in alkaline solution with the same ph as the Hoffmann-La Roche solution and Schering's Trinktabletten . . . [Full Text PDF of this Article]


Author Affiliations

CHICAGO

From the Department of Medicine, Rush Medical College, and the Presbyterian Hospital.


Footnotes

Aided by a grant from the Committee on Scientific Research of the American Medical Association.

A brief abstract of this article was published in the Proceedings of the American Society for Clinical Investigation for 1933 (J. Clin. Investigation 12:990, 1933).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1933 American Medical Association. All Rights Reserved.